Yan Gao1, Mengxiao Liu2, Zhiguo Ju3, and Ximing Wang4
1Department of Radiology, Shandong Provincial Hospital, Shandong University, Jinan, China, 2Siemens Healthineers, Shanghai, China, 3College of Medical Imaging, Shanghai University of Medicine & Health Science, Shanghai, China, 4Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
Synopsis
Keywords: Myocardium, Heart
The prognosis of LVNC is remarkably heterogeneous,
with heart failure (HF), ventricular arrhythmias (VAs) and systemic embolisms
(SEs) being the most frequent cardiovascular complications but no specific
recommendations are available at present. In the present study, we aimed to investigate
whether LV entropy could efficiently predict major adverse cardiac events
(MACEs) in patients with LVNC incremental to established clinical and imaging
risk markers.
Introduction
The
prognosis of LVNC is remarkably heterogeneous, with heart failure (HF),
ventricular arrhythmias (VAs) and systemic embolisms (SEs), and the risk
stratification of left ventricular noncompaction (LVNC) is still ambiguous. Myocardial
fibrosis detected by CMR using LGE imaging is the current gold standard to
noninvasively visualize the underlying scar architecture and inform towards
risk of scar-related cardiac events (1,2). However, this
signal intensity (SI)-based method relies on operator-defined areas with categorical
thresholds or areas with remote myocardium as reference to assess the extent of
pixels exceeding the setting threshold (3), and mainly focus
on measuring scar presence, pattern, and extent, which have limitations in
assessing non-enhanced regions of the myocardium (4). LV entropy
derived from late gadolinium enhancement (LGE) in cardiac magnetic resonance
(CMR) may serve as the substrate of major adverse cardiovascular events (MACEs).
The purpose of this study was to investigate the value of LV entropy, as a
novel measurement of myocardial heterogeneity, for predicting MACEs in LVNC patients. Methods
143
consecutive patients undergoing CMR for LVNC were included and followed for
MACEs defined by all-cause death, ventricular arrhythmia (VA) requiring
therapy, systemic embolisms or heart failure hospitalization. All CMR
examinations were performed using 3T scanners (MAGNETOM Prisma, Siemens
Healthcare, Erlangen, Germany). The conventional analysis was performed offline
using dedicated commercially available software (Medis Suite v3.1, Medis,
Leiden, the Netherlands) following standardized recommendations by two
experienced researchers blinded to clinical data. For the LV entropy
calculations, epicardial and endocardial contours were manually delineated on
the short-axis images of LGE with careful exclusion of any blood pool signal.
LV entropy values were directly derived from the distribution of pixel signal
intensities of the LV myocardium on LGE images and automatically generated
using Research Mass (Leiden University Medical Center, Leiden, the Netherlands)
according to the following formula (3,5):
Entropy = - Σni=1P(xi)logbP(xi)
where P(xi) is the probability distribution of
signal intensities, x is
signal intensity, and b is any chosen base (Research Mass uses 2). The
comparisons among clinical variables, CMR-based parameters and entropy were
performed with χ2 tests, Student's t-tests, Mann-Whitney U tests for
categorical variables, normally, and skewed distributed continuous variables,
respectively. A p-value < 0.05 were considered to be statistically
significant. Results
One
hundred and forty-three patients (mean age 40 years, 64.3% male) were followed
for a median of 3.2 years and fifty-two (36.4%) experienced MACE. Left ventricular
end-diastolic diameter (LVEDD), LV end-diastolic volume (LVEDV) index, LV
end-systolic volume (LVESV) index, LV ejection fraction (LVEF), LGE extent and LV
entropy showed association with MACE. LV entropy maintained independent association
with MACEs (HR: 2.49; 95% CI: 1.22-5.10; p < 0.001) in multivariable
analysis. Entropy was also strong independent predictor of MACEs in patients with
and without LGE (HR: 2.49, 95% CI 1.97-3.73, p < 0.001; HR: 1.85, 95%
CI: 1.23-3.95, p = 0.048, respectively). Discussion
LV
entropy assessment in patients with myocardial scar indirectly includes the
features of the peri-fibrosis area. Heterogeneity in this area has been proven
to represent myocardial tissue that is arrhythmogenic (6). LV entropy derived
from the entirety of the signal intensity distribution is threshold-independent
and possibly allows detection of more gradual differences in myocardial texture
(7).Conclusions
LV
entropy can predict MACEs in LVNC patients and provided incremental prognostic
value on top of LVEF and LGE. LV entropy may help risk stratification in LVNC patients
with absence of myocardial scar.Acknowledgements
NoneReferences
1. Hennig A, Salel M, Sacher F et al.
High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic
resonance imaging to identify the underlying substrate of ventricular
arrhythmia. Europace : European pacing, arrhythmias, and cardiac electrophysiology
: journal of the working groups on cardiac pacing, arrhythmias, and cardiac
cellular electrophysiology of the European Society of Cardiology
2018;20:f179-f191.
2. Wu E, Judd RM, Vargas JD, Klocke FJ,
Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of
healed Q-wave and non-Q-wave myocardial infarction. Lancet (London, England)
2001;357:21-8.
3. Androulakis AFA, Zeppenfeld K, Paiman
EHM et al. Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for
Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients.
JACC Clin Electrophysiol 2019;5:480-489.
4. Di Marco A, Anguera I, Schmitt M et al.
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or
Sudden Death in Dilated Cardiomyopathy: Systematic Review and
Meta-Analysis. JACC Heart failure 2017;5:28-38.
5. Muthalaly RG, Kwong RY, John RM et al.
Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients
With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
JACC Cardiovascular imaging 2019;12:1177-1184.
6. Schmidt A, Azevedo CF, Cheng A et al.
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced
cardiac arrhythmia susceptibility in patients with left ventricular dysfunction.
Circulation 2007;115:2006-14.
7.Antiochos P, Ge Y, van der Geest RJ et
al. Entropy as a Measure of Myocardial Tissue Heterogeneity in Patients With
Ventricular Arrhythmias. JACC Cardiovascular imaging 2022;15:783-792.